Artificial cell bioencapsulation in macro, micro, nano, and molecular dimensions: Keynote lecture

被引：21

作者：

Chang, TMS

机构：

[1] McGill Univ, Artificial Cells & Organs Res Ctr, MSSS FRSQ Res Grp Transfus Med, Montreal, PQ H3G 1H6, Canada

[2] McGill Univ, Fac Med, Dept Physiol, Montreal, PQ H3G 1H6, Canada

[3] McGill Univ, Fac Med, Dept Med, Montreal, PQ H3G 1H6, Canada

[4] McGill Univ, Fac Med, Dept Biomed Engn, Montreal, PQ H3G 1H6, Canada

来源：

ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY | 2004年 / 32卷 / 01期

关键词：

artificial cells; bioencapsulation; nanocapsules; microcapsules; macrocapsules; encapsulation; enzyme therapy; cell therapy; gene therapy; blood substitutes; drug delivery;

D O I：

10.1081/BIO-120028665

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Artificial cells now ranges from macro-dimensions, to micron-dimensions, to nano-dimensions, and to molecular dimensions. Those in the macro-dimensions are suitable for use in the bioencapsulation of cells, tissues, microorganisms, and bioreactants. Those in the micron-dimensions are suitable for the bioencapsulation of enzymes, microorganisms, peptides, drugs, vaccine, and other materials. Those in the nano-dimension are being used for blood substitutes and carriers for enzymes, peptides, drugs, etc. Those in the molecular-dimensions are used as blood substitutes, crosslinked enzymes etc.

引用

页码：1 / 23

页数：23

共 61 条

[1] Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients [J].

Aebischer, P ;

Schluep, M ;

Deglon, N ;

Joseph, JM ;

Hirt, L ;

Heyd, B ;

Goddard, M ;

Hammang, JP ;

Zurn, AD ;

Kato, AC ;

Regli, F ;

Baetge, EE .

NATURE MEDICINE, 1996, 2 (06) :696-699

[2] PHENYLALANINE AMMONIA-LYASE IMMOBILIZED IN MICROCAPSULES FOR THE DEPLETION OF PHENYLALANINE IN PLASMA IN PHENYLKETONURIC RAT MODEL [J].

BOURGET, L ;

CHANG, TMS .

BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 883 (03) :432-438

[3] HEPATOCYTES IMMOBILIZED BY MICROENCAPSULATION IN ARTIFICIAL CELLS - EFFECTS ON HYPERBILIRUBINEMIA IN GUNN-RATS [J].

BRUNI, S ;

CHANG, TMS .

BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS, 1989, 17 (04) :403-411

[4] Transforming growth factor-β1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts -: art. no. 8 [J].

Chang, NS .

BMC CELL BIOLOGY, 2002, 3 (1)

[5]

Chang T M, 1995, Biotechnol Annu Rev, V1, P267

[6] Future generations of red blood cell substitutes [J].

Chang, TMS .

JOURNAL OF INTERNAL MEDICINE, 2003, 253 (05) :527-535

[7] Live E. coli cells to treat uremia [J].

T.M.S. Chang .

Nature Medicine, 1997, 3 (1) :3-4

[8] Therapeutic uses of microencapsulated genetically engineered cells [J].

Chang, TMS ;

Prakash, S .

MOLECULAR MEDICINE TODAY, 1998, 4 (05) :221-227

[9]

CHANG TMS, 1988, BIOMATER ARTIF CELL, V16, P1

[10] IN-VIVO EFFECTS OF SEMIPERMEABLE MICROCAPSULES CONTAINING L-ASPARAGINASE ON 6C3HED LYMPHOSARCOMA [J].

CHANG, TMS .

NATURE, 1971, 229 (5280) :117-&

← 1 2 3 4 5 6 7 →